Public tenders in Germany

725 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. ILO), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410427-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a Non-Exclusive Discount Agreement under § 130a Abs. 8 SGB V for the Active Ingredient Fesoterodin, ATC Code G04BD11, for the Period from 01.08.2026 to 31.07.2028 (including Extension Option for 1x12 Months)

DAK-Gesundheit, HamburgTED 406821-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Calcipotriol (excluding Dafo. CRE), ATC D05AX02 for the period from 01.08.2026 to 31.07.2028 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 412848-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Granisetron (excluding Dafo. PFT), ATC A04AA02 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 410634-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Varenicline, ATC N07BA03, for the period 01.08.2026 – 31.07.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 410962-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clonazepam, ATC N03AE01 for the period 01.08.2026 - 31.07.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 409047-2026

€11 lot, 2 years

Tue 5 Jun12:00 in Berlin

950days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brivaracetam, ATC N03AX23 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496840-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Biperiden (excluding strength 4 mg), ATC N04AA02, for the period 01.09.26 – 31.08.28 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 495070-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Betamethasone + Clotrimazole, ATC D01AC20 for the period 01.09.2026 - 31.08.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 496714-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Cefixime (excluding Dafo. FTA), ATC J01DD08 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495268-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lidocaine, ATC N01BB02 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495164-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Perampanel, ATC N03AX22 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496953-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brinzolamide + Brimonidine, ATC S01EC24 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495328-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Perindopril arginine + Amlodipine + Indapamide, ATC C09BX01, for the period 01.9.26–31.8.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495404-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Capsaicin, ATC N01BX04, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496025-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Oxybutynin (excluding Dafo. PFT), ATC code G04BD04 for the period from 01.09.26 to 31.08.28 (including V.-option for 1x12 months)

DAK-Gesundheit, HamburgTED 494810-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Miconazole + Fluprednidene, ATC D01AC20 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495339-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Clotrimazole + Hydrocortisone, ATC D01AC20, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495637-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Cefadroxil (excluding Dafo. TAB), ATC J01DB05, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495513-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Hydrocortisone (excluding Dafo. TVW), ATC H02AB09 for the period 01.09.26 - 31.08.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 496057-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.